Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.

Planchard, David; Jänne, Pasi A; Cheng, Ying; Yang, James C-H; Yanagitani, Noriko; Kim, Sang-We; Sugawara, Shunichi; Yu, Yan; Fan, Yun; Geater, Sarayut L; Laktionov, Konstantin; Lee, Chee K; Valdiviezo, Natalia; Ahmed, Samreen; Maurel, Jean-Marc; Andrasina, Igor; Goldman, Jonathan; Ghiorghiu, Dana; Rukazenkov, Yuri; Todd, Alex; Kobayashi, Kunihiko.

N Engl J Med ; 389(21): 1935-1948, 2023 Nov 23.

Artículo en Inglés | MEDLINE | ID: mdl-37937763

2.

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

Li, Bob T; Smit, Egbert F; Goto, Yasushi; Nakagawa, Kazuhiko; Udagawa, Hibiki; Mazières, Julien; Nagasaka, Misako; Bazhenova, Lyudmila; Saltos, Andreas N; Felip, Enriqueta; Pacheco, Jose M; Pérol, Maurice; Paz-Ares, Luis; Saxena, Kapil; Shiga, Ryota; Cheng, Yingkai; Acharyya, Suddhasatta; Vitazka, Patrik; Shahidi, Javad; Planchard, David; Jänne, Pasi A.

N Engl J Med ; 386(3): 241-251, 2022 01 20.

Artículo en Inglés | MEDLINE | ID: mdl-34534430

3.

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.

Smit, Egbert F; Felip, Enriqueta; Uprety, Dipesh; Nagasaka, Misako; Nakagawa, Kazuhiko; Paz-Ares Rodríguez, Luis; Pacheco, Jose M; Li, Bob T; Planchard, David; Baik, Christina; Goto, Yasushi; Murakami, Haruyasu; Saltos, Andreas; Pereira, Kaline; Taguchi, Ayumi; Cheng, Yingkai; Yan, Qi; Feng, Wenqin; Tsuchihashi, Zenta; Jänne, Pasi A.

Lancet Oncol ; 25(4): 439-454, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38547891

4.

Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.

Mezquita, Laura; Oulhen, Marianne; Aberlenc, Agathe; Deloger, Marc; Aldea, Mihaela; Honore, Aurélie; Lecluse, Yann; Howarth, Karen; Friboulet, Luc; Besse, Benjamin; Planchard, David; Farace, Françoise.

Br J Cancer ; 130(4): 682-693, 2024 03.

Artículo en Inglés | MEDLINE | ID: mdl-38177660

5.

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.

Postel-Vinay, Sophie; Coves, Juan; Texier, Matthieu; Aldea, Mihaela; Gazzah, Anas; Dómine, Manuel; Planchard, David; De Las Peñas, Ramon; Sala Gonzalez, Ma Angeles; Viteri, Santiago; Perez, Javier; Ortega, Ana Laura; Moran, Teresa; Camps, Carlos; Lopez-Martin, Ana; Provencio, Mariano; Soria, Jean-Charles; Besse, Benjamin; Massuti, Bartomeu; Rosell, Rafael.

Br J Cancer ; 130(3): 417-424, 2024 02.

Artículo en Inglés | MEDLINE | ID: mdl-38097741

6.

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.

Ramalingam, Suresh S; Vansteenkiste, Johan; Planchard, David; Cho, Byoung Chul; Gray, Jhanelle E; Ohe, Yuichiro; Zhou, Caicun; Reungwetwattana, Thanyanan; Cheng, Ying; Chewaskulyong, Busyamas; Shah, Riyaz; Cobo, Manuel; Lee, Ki Hyeong; Cheema, Parneet; Tiseo, Marcello; John, Thomas; Lin, Meng-Chih; Imamura, Fumio; Kurata, Takayasu; Todd, Alexander; Hodge, Rachel; Saggese, Matilde; Rukazenkov, Yuri; Soria, Jean-Charles.

N Engl J Med ; 382(1): 41-50, 2020 01 02.

Artículo en Inglés | MEDLINE | ID: mdl-31751012

7.

Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.

Hwang, Michael; Chia, Yen Lin; Zheng, Yanan; Chen, Cecil Chi-Keung; He, Jimmy; Song, Xuyang; Zhou, Diansong; Goldberg, Sarah B; Siu, Lillian L; Planchard, David; Peters, Solange; Mann, Helen; Krug, Lee; Even, Caroline.

Br J Clin Pharmacol ; 89(5): 1601-1616, 2023 05.

Artículo en Inglés | MEDLINE | ID: mdl-36454221

8.

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.

Zauderer, Marjorie G; Szlosarek, Peter W; Le Moulec, Sylvestre; Popat, Sanjay; Taylor, Paul; Planchard, David; Scherpereel, Arnaud; Koczywas, Marianna; Forster, Martin; Cameron, Robert B; Peikert, Tobias; Argon, Evren Kocabas; Michaud, Neil R; Szanto, Attila; Yang, Jay; Chen, Yingxue; Kansra, Vikram; Agarwal, Shefali; Fennell, Dean A.

Lancet Oncol ; 23(6): 758-767, 2022 06.

Artículo en Inglés | MEDLINE | ID: mdl-35588752

9.

Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. Reply.

Planchard, David; Jänne, Pasi A; Kobayashi, Kunihiko.

N Engl J Med ; 390(5): 478-479, 2024 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-38294984

10.

Ongoing progress in BRAF-mutated non-small cell lung cancer.

Abdayem, Pamela; Planchard, David.

Clin Adv Hematol Oncol ; 20(11): 662-672, 2022 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-36331404

11.

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Soria, Jean-Charles; Ohe, Yuichiro; Vansteenkiste, Johan; Reungwetwattana, Thanyanan; Chewaskulyong, Busyamas; Lee, Ki Hyeong; Dechaphunkul, Arunee; Imamura, Fumio; Nogami, Naoyuki; Kurata, Takayasu; Okamoto, Isamu; Zhou, Caicun; Cho, Byoung Chul; Cheng, Ying; Cho, Eun Kyung; Voon, Pei Jye; Planchard, David; Su, Wu-Chou; Gray, Jhanelle E; Lee, Siow-Ming; Hodge, Rachel; Marotti, Marcelo; Rukazenkov, Yuri; Ramalingam, Suresh S.

N Engl J Med ; 378(2): 113-125, 2018 01 11.

Artículo en Inglés | MEDLINE | ID: mdl-29151359

12.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia, Scott J; Villegas, Augusto; Daniel, Davey; Vicente, David; Murakami, Shuji; Hui, Rina; Kurata, Takayasu; Chiappori, Alberto; Lee, Ki H; de Wit, Maike; Cho, Byoung C; Bourhaba, Maryam; Quantin, Xavier; Tokito, Takaaki; Mekhail, Tarek; Planchard, David; Kim, Young-Chul; Karapetis, Christos S; Hiret, Sandrine; Ostoros, Gyula; Kubota, Kaoru; Gray, Jhanelle E; Paz-Ares, Luis; de Castro Carpeño, Javier; Faivre-Finn, Corinne; Reck, Martin; Vansteenkiste, Johan; Spigel, David R; Wadsworth, Catherine; Melillo, Giovanni; Taboada, Maria; Dennis, Phillip A; Özgüroglu, Mustafa.

N Engl J Med ; 379(24): 2342-2350, 2018 12 13.

Artículo en Inglés | MEDLINE | ID: mdl-30280658

13.

Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?

Hadoux, Julien; Blanchard, Pierre; Scoazec, Jean-Yves; Burtin, Pascal; Planchard, David; Malka, David; Berdelou, Amandine; Boige, Valérie; Duvillard, Pierre; Leboulleux, Sophie; Faron, Matthieu; Tselikas, Lambros; Deutsch, Eric; Ducreux, Michel; Baudin, Eric.

Neuroendocrinology ; 111(1-2): 139-145, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-31639792

14.

Biosimilars in an era of rising oncology treatment options.

Peeters, Marc; Planchard, David; Pegram, Mark; Gonçalves, João; Bocquet, François; Jang, Harah.

Future Oncol ; 17(29): 3881-3892, 2021 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-34189937

15.

Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.

Garassino, Marina C; Paz-Ares, Luis; Hui, Rina; Faivre-Finn, Corinne; Spira, Alex; Planchard, David; Özgüroglu, Mustafa; Daniel, Davey; Vicente, David; Murakami, Shuji; Langer, Corey; Senan, Suresh; Spigel, David; Rydén, Anna; Zhang, Yiduo; O'Brien, Cathy; Dennis, Phillip A; Antonia, Scott J.

Future Oncol ; 17(10): 1165-1184, 2021 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-33583206

16.

Feasibility of a video-based cognitive behavioral therapy for insomnia in French adult cancer outpatients: results from the Sleep-4-All-1 study.

Boinon, Diane; Charles, Cécile; Fasse, Léonor; Journiac, Jonathan; Pallubicki, Gloria; Lamore, Kristopher; Ninot, Grégory; Guerdoux-Ninot, Estelle; Gouy, Sébastien; Albiges, Laurence; Delaloge, Suzette; Malka, David; Planchard, David; Savard, Josée; Dauchy, Sarah.

Support Care Cancer ; 29(10): 5883-5894, 2021 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-33761001

17.

Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.

Park, Wungki; Mezquita, Laura; Okabe, Naoyuki; Chae, Young Kwang; Kwon, Deukwoo; Saravia, Diana; Auclin, Edouard; Planchard, David; Caramella, Caroline; Ferrara, Roberto; Agte, Sarita; Oh, Michael; Mudad, Raja; Jahanzeb, Mohammad; Suzuki, Hiroyuki; Besse, Benjamin; Lopes, Gilberto.

Br J Cancer ; 122(3): 340-347, 2020 02.

Artículo en Inglés | MEDLINE | ID: mdl-31761899

18.

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Antonia, Scott J; Villegas, Augusto; Daniel, Davey; Vicente, David; Murakami, Shuji; Hui, Rina; Yokoi, Takashi; Chiappori, Alberto; Lee, Ki H; de Wit, Maike; Cho, Byoung C; Bourhaba, Maryam; Quantin, Xavier; Tokito, Takaaki; Mekhail, Tarek; Planchard, David; Kim, Young-Chul; Karapetis, Christos S; Hiret, Sandrine; Ostoros, Gyula; Kubota, Kaoru; Gray, Jhanelle E; Paz-Ares, Luis; de Castro Carpeño, Javier; Wadsworth, Catherine; Melillo, Giovanni; Jiang, Haiyi; Huang, Yifan; Dennis, Phillip A; Özgüroglu, Mustafa.

N Engl J Med ; 377(20): 1919-1929, 2017 11 16.

Artículo en Inglés | MEDLINE | ID: mdl-28885881

19.

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.

Yamamoto, Nobuyuki; Hayashi, Hidetoshi; Planchard, David; Morán, Teresa; Gregorc, Vanesa; Dowell, Jonathan; Sakai, Hiroshi; Yoh, Kiyotaka; Nishio, Makoto; Cortot, Alexis B; Benhadji, Karim A; Soni, Nital; Huang, Jinhong; Makris, Lukas; Cedres, Susana.

Invest New Drugs ; 38(5): 1588-1597, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32246224

20.

Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.

Seban, Romain-David; Mezquita, Laura; Berenbaum, Arnaud; Dercle, Laurent; Botticella, Angela; Le Pechoux, Cécile; Caramella, Caroline; Deutsch, Eric; Grimaldi, Serena; Adam, Julien; Ammari, Samy; Planchard, David; Leboulleux, Sophie; Besse, Benjamin.

Eur J Nucl Med Mol Imaging ; 47(5): 1147-1157, 2020 05.

Artículo en Inglés | MEDLINE | ID: mdl-31754795

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: